IRIS
DANIELI, Maria Giovanna
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.308
EU - Europa 1.913
AS - Asia 564
AF - Africa 70
SA - Sud America 17
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 3
Totale 5.879
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.237
IT - Italia 423
UA - Ucraina 373
IE - Irlanda 237
SG - Singapore 225
SE - Svezia 211
DE - Germania 201
CN - Cina 156
DK - Danimarca 137
GB - Regno Unito 111
FI - Finlandia 84
TR - Turchia 78
KR - Corea 72
CA - Canada 69
FR - Francia 67
CI - Costa d'Avorio 33
MA - Marocco 33
IN - India 19
RU - Federazione Russa 19
NL - Olanda 18
BE - Belgio 15
BR - Brasile 14
AT - Austria 4
AU - Australia 4
RS - Serbia 4
TW - Taiwan 4
AR - Argentina 3
EU - Europa 3
PL - Polonia 3
CH - Svizzera 2
ID - Indonesia 2
PK - Pakistan 2
UG - Uganda 2
BD - Bangladesh 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
HK - Hong Kong 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
NG - Nigeria 1
PH - Filippine 1
RO - Romania 1
Totale 5.879
Salva come PNG Salva come JPEG
Città #
Jacksonville 389
Chandler 388
Fairfield 257
Dublin 231
Boardman 227
Ashburn 225
Wilmington 147
Woodbridge 144
New York 115
Singapore 102
Ann Arbor 97
Seattle 97
Houston 93
Lawrence 87
Princeton 87
Des Moines 82
San Mateo 82
Cambridge 66
Montréal 62
Centro 59
Mcallen 49
Munich 45
San Diego 41
Abidjan 33
Turin 28
Washington 23
Beijing 22
Los Angeles 21
Helsinki 19
Milan 18
Pune 17
Redmond 16
Brussels 14
Shanghai 14
Ancona 13
Wuhan 13
Saint Petersburg 12
Castelfidardo 11
Guangzhou 10
Norwalk 10
Dallas 9
London 9
Chiaravalle 8
Kilburn 8
Palermo 7
Rome 6
Rotella 5
Alghero 4
Auburn Hills 4
Belgrade 4
Bergamo 4
Brescia 4
Chiswick 4
Falls Church 4
Florence 4
Genoa 4
Iesi 4
Jiaxing 4
Montemarciano 4
Naples 4
Ottawa 4
Porto 4
Sirolo 4
Tolentino 4
Vallefoglia 4
Aarhus 3
Catania 3
Fano 3
Frankfurt am Main 3
Groningen 3
Lecce 3
Monza 3
Palm Beach Gardens 3
Prescot 3
Ronciglione 3
Shenzhen 3
Sydney 3
Vienna 3
Warsaw 3
Amsterdam 2
Aurora 2
Bensalem 2
Buenos Aires 2
Cedar Knolls 2
Cerveteri 2
Chengdu 2
Civitanova Marche 2
Clifton 2
Copertino 2
Dracut 2
Falerone 2
Fayetteville 2
Filottrano 2
Hanover 2
Islington 2
Jesi 2
Jinhua 2
Kampala 2
Macerata 2
Magenta 2
Totale 3.674
Salva come PNG Salva come JPEG
Nome #
Prurigo nodularis as the first manifestation of a common variable immunodeficiency 299
Colonna vertebrale. Midollo spinale. Imaging 147
La scelta della maternità. Una guida alla decisione per le donne con LES 105
CENTRAL NERVOUS SYSTEM INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITHOUT OVERT NEUROPSYCHIATRIC MANIFESTATIONS 103
IMMUNOSUPPRESSIVE THERAPY IN LUPUS NEPHRITIS: A RANDOMISED TRIAL OF LOW DOSE VERSUS HIGH DOSE INTRAVENOUS CYCLOPHOSPHAMIDE. THE EUROLUPUS NEPHRITIS TRIAL. 102
The EuroMyositis registry: An international collaborative tool to facilitate myositis research 99
Clinical features and follow-up in patients with 22q11.2 deletion syndrome. 98
Cardiac involvement in polymyositis and dermatomyositis 98
Global longitudinal strain measured by speckle tracking identifies subclinical heart involvement in patients with systemic sclerosis 96
Subcutaneous IgG in the Myositis Spectrum Disorders 89
A Case of CVID-Associated Inflammatory Bowel Disease with CTLA-4 Mutation Treated with Abatacept 86
Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. 84
Subcutaneous immunoglobulin in inflammatory myopathies: efficacy in different organ systems 84
The ten-year follow-up data of the Euro-lupus Nephritis Trial comparing low-dose versus high-dose intravenous cyclophosphamide. 81
7th International Immunoglobulin Conference: Immunomodulation. 81
Subcutaneous immunoglobulin in polymyositis and dermatomyositis: a novel application. 79
Incidence of malignancy in patients with common variable immunodeficiency according to therapeutic delay: an Italian retrospective, monocentric cohort study 77
Overexpression of the cytokine BAFF and autoimmunity risk 76
Two single-nucleotide polymorphisms in the 5' and 3' ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. 76
Antibodies to mycobacterial 65 kDa heat shock protein in systemic sclerosis (scleroderma). 75
Self-administered hyaluronidase-facilitated subcutaneous immunoglobulin therapy in complicated primary antibody deficiencies 75
Azathioprine versus mycophenolate mofetil for long-term immunosuppression in lupus nephritis: Results from the MAINTAIN Nephritis Trial 75
The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019) 74
Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. 70
Clinical and serological associations of ribosomal P autoantibodies in systemic lupus erythematosus: prospective evaluation in a large cohort of Italian patients. 70
Subclinical Cardiac Dysfunction in Polymyositis and Dermatomyositis: A Speckle-tracking Case-control Study 70
A proteinuria cut-off level of 0.7 g /day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: Data from the MAINTAIN Nephritis Trial 70
6th International Immunoglobulin Symposium: poster presentations. 69
Facilitated Subcutaneous Immunoglobulin (fSCIg) in Autoimmune Cytopenias Associated with Common Variable Immunodeficiency 69
Functional variants in the B-cell gene BANK1 are associated with systemic lupus erythematosus. 69
Dr. Guerra, et al reply 68
La terapia immunosoppressiva nelle miositi refratttarie 66
Risk factors for Sjögren's syndrome: a case-control study. 66
Familial autoimmunity as a risk factor for systemic lupus erythematosus and vice versa: a case-control study. 65
Undifferentiated connective tissue disease: natural history and evolution into definite CTD assessed in 84 patients initially diagnosed as early UCTD. 65
Active hepatitis C virus infection in bone marrow and peripheral blood mononuclear cells from patients with mixed cryoglobulinaemia. 65
Autoimmune thyroid diseases in patients with undifferentiated connective tissue disease. 65
Long term effectiveness of intravenous immunoglobulin in Churg-Strauss syndrome. 65
Clinical Associations of Biallelic and Monoallelic TNFRSF13B Variants in Italian Primary Antibody Deficiency Syndromes 64
Association tests with systemic lupus erythematosus (SLE) of IL10 arkers indicate a direct involvement of a CA repeat in the 5' regulatory region 63
Autoimmunità, Gravidanza, Contraccezione, Terapia ormonale 63
Serum levels of soluble interleukin-2 receptor in patients with systemic lupus erythematosus and systemic idiopathic vasculitis. 63
Management of a pregnant woman with common variable immunodeficiency and previous reactions to intravenous IgG administration 62
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficiencies 62
Juvenile rheumatoid arthritis patients manifest immune reactivity to the mycobacterial 65-kDa heat shock protein, to its 180-188 peptide, and to a partially homologous peptide of the proteoglycan link protein. 61
la terapia con immunoglobuline endovena nel trattamento delle malattie autoimmuni 61
Bullous SLE: response to methotrexate and relationship with disease activity 60
Intravenous immunoglobulin as add on treatment with mycophenolate mofetil in severe myositis. 57
Prolactin and prolactin receptor gene polymorphisms in multiple sclerosis and systemic lupus erythematosus. 57
Cyclosporin A and intravenous immunoglobulin treatment in polymyositis/dermatomyositis. 56
Repeat kidney biopsies fail to detect differences between azathioprine and mycophenolate mofetil maintenance therapy for lupus nephritis: data from the MAINTAIN Nephritis Trial 56
Impact of treatment on survival in polymyositis and dermatomyositis. A single-centre long-term follow-up study. 55
Identification of a new putative functional IL18 gene variant through an association study in systemic lupus erythematosus 55
Subcutaneous immunoglobulins in ocular myositis. 54
Long-term follow-up of the MAINTAIN Nephritis Trial, comparing azathioprine and mycophenolate mofetil as maintenance therapy of lupus nephritis 54
Efficacy and safety of intravenous and subcutaneous tocilizumab in a cohort of patients affected by rheumatoid arthritis in real-life 54
Subcutaneous IgG in immune-mediate diseases: proposed mechanisms of action and literature review. 53
Autoimmunità Gravidanza Contraccezione Terapia Ormonale 53
Potential Anti-Tumor Activity of Intravenous and Subcutaneous Immunoglobulin 53
Systemic lupus in Europe at the change of the millennium: lessons from the "Euro-lupus Project" 53
Recurrent myelitis in common variable immunodeficiency successfully managed with high-dose subcutaneous immunoglobulin. 52
The European Society for Immunodeficiencies (ESID) registry 2014 51
Preliminary report on the use of subcutaneous immunoglobulin in severe inflammatory myopathies 51
Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations 51
Rare variants in the TREX1 gene and susceptibility to autoimmune diseases. 50
Intravenous Immunoglobulin and Mycophenolate Mofetil for Long-Standing Sensory Neuronopathy in Sjögren's Syndrome 50
Ultrasonographic contrast-enhanced study of sicca syndrome 50
Sinchronised therapy and high-dose cyclophosphamide in proliferative lupus nephritis. 50
Open-label study on treatment with 20 % subcutaneous IgG administration in polymyositis and dermatomyositis. 49
Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagnaet al 49
High-dose Facilitated subcutaneous Immunoglobulin in a Patient with refractory Polymyositis and severe Interstitial Lung disease 49
Quantitative assessment of salivary gland inflammatory infiltration in primary Sjögren's syndrome: its relationship to different demographic, clinical and serological features of the disorder. 45
Immunohistochemical localization of intracellular and extracellular associated TGF beta in the skin of patients with systemic sclerosis (scleroderma) and primary Raynaud's phenomenon. 45
Common Variable Immunodeficiency in Elderly Patients: A Long-Term Clinical Experience 45
Platelet-activating factor acetylhydrolase: A biomarker in Hymenoptera venom allergy? 43
Splenic microcalcifications in systemic lupus erythematosus 42
Intravenous immunoglobulin as an important adjunct in the prevention and therapy of coronavirus 2019 disease 42
Immunoglobulin Treatment inPolymyositis and Dermatomyositis 40
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunity 40
Replacement and Immunomodulatory Activities of 20% Subcutaneous Immunoglobulin Treatment: A Single-Center Retrospective Study in Autoimmune Myositis and CVID Patients 39
Hydroxychloroquine-induced seizure in a patient with systemic lupus erythematosus. 38
Subcutaneous immunoglobulin G in idiopathic inflammatory myopathies: therapeutic implications. 38
Lessons from the "Euro-Lupus Cohort". 37
Valutazione obbiettiva strutturata della competenza clinica (osce) 36
Efficacy and safety of intravenous and subcutaneous immunoglobulin therapy in idiopathic inflammatory myopathy: A systematic review and meta-analysis 36
Differential risk of non-Hodgkin's lymphoma in Italian patients with primary Sjögren's syndrome. 34
A machine learning analysis to predict the response to intravenous and subcutaneous immunoglobulin in inflammatory myopathies. A proposal for a future multi-omics approach in autoimmune diseases 33
Alarmins in autoimmune diseases 30
A machine learning analysis to evaluate the outcome measures in inflammatory myopathies 30
Autoimmunity, COVID-19, Post-COVID19 Syndrome and COVID-19 Vaccination 30
Heterogeneity of the humoral anti-HCV/E2 response in persistently infected patients as demonstrated by divergent patterns of inhibition of the binding of anti-HCV/E2 human monoclonal antibodies. 30
The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet) 29
Oxidative stress, mitochondrial dysfunction, and respiratory chain enzyme defects in inflammatory myopathies 25
ANCA-negative EGPA: only eosinophils without vasculitis? Insights from anti-T2 biologics 19
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study 17
Systemic sclerosis and COVID-19 vaccine safety: short-term insights from the global COVID-19 vaccination in autoimmune disease (COVAD) survey 15
Follicular helper T cell signature of replicative exhaustion, apoptosis, and senescence in common variable immunodeficiency 15
[Therapy of refractory rheumatoid arthritis. Cyclosporin and methotrexate combination] 14
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis 14
Hymenoptera Venom Allergy and Anaphylaxis 9
Totale 6.002
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.621
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.621
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020411 0 0 0 0 0 57 112 11 86 3 36 106
2020/20211.137 66 114 141 5 154 58 131 60 120 87 134 67
2021/2022674 29 176 15 34 3 35 45 58 46 44 74 115
2022/20231.263 104 115 99 104 104 169 5 82 324 13 99 45
2023/2024921 160 40 56 126 144 188 18 34 10 32 19 94
2024/2025567 135 171 76 31 66 88 0 0 0 0 0 0
Totale 6.031